HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - NYSE:HIMS - US4330001060 - Common Stock
52.54 USD
-5.33 (-9.21%)
53.53 USD
+0.99 (+1.88%)
Overall HIMS gets a fundamental rating of 6 out of 10. We evaluated HIMS against 101 industry peers in the Health Care Providers & Services industry. HIMS has an average financial health and profitability rating. HIMS is valued quite expensively, but it does show have an excellent growth rating. This makes HIMS very considerable for growth investing!
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
HIMS had negative earnings in 4 of the past 5 years.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
HIMS has a better Return On Assets (10.31%) than 95.05% of its industry peers.
HIMS has a better Return On Equity (34.41%) than 95.05% of its industry peers.
HIMS has a Return On Invested Capital of 6.74%. This is in the better half of the industry: HIMS outperforms 67.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROIC | 6.74% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a Profit Margin of 9.62%. This is amongst the best in the industry. HIMS outperforms 92.08% of its industry peers.
With a decent Operating Margin value of 6.80%, HIMS is doing good in the industry, outperforming 66.34% of the companies in the same industry.
Looking at the Gross Margin, with a value of 76.20%, HIMS belongs to the top of the industry, outperforming 89.11% of the companies in the same industry.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HIMS has more shares outstanding
HIMS has more shares outstanding than it did 5 years ago.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 7.31 indicates that HIMS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.31, HIMS belongs to the top of the industry, outperforming 91.09% of the companies in the same industry.
The Debt to FCF ratio of HIMS is 8.11, which is on the high side as it means it would take HIMS, 8.11 years of fcf income to pay off all of its debts.
HIMS has a Debt to FCF ratio of 8.11. This is comparable to the rest of the industry: HIMS outperforms 56.44% of its industry peers.
A Debt/Equity ratio of 1.72 is on the high side and indicates that HIMS has dependencies on debt financing.
HIMS has a worse Debt to Equity ratio (1.72) than 71.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Altman-Z | 7.31 |
ROIC/WACC0.77
WACC8.77%
2.3 Liquidity
HIMS has a Current Ratio of 4.98. This indicates that HIMS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.98, HIMS belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
HIMS has a Quick Ratio of 4.46. This indicates that HIMS is financially healthy and has no problem in meeting its short term obligations.
HIMS's Quick ratio of 4.46 is amongst the best of the industry. HIMS outperforms 92.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 900.00%, which is quite impressive.
The Earnings Per Share has been growing by 60.35% on average over the past years. This is a very strong growth
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 88.69%.
Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
3.2 Future
Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 41.75% on average per year.
The Revenue is expected to grow by 21.25% on average over the next years. This is a very strong growth
EPS Next Y14.28%
EPS Next 2Y24.45%
EPS Next 3Y24.18%
EPS Next 5Y41.75%
Revenue Next Year59.67%
Revenue Next 2Y38.12%
Revenue Next 3Y31.04%
Revenue Next 5Y21.25%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 65.67, the valuation of HIMS can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
HIMS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.86.
HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 62.82.
The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
HIMS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.68 | ||
| Fwd PE | 62.82 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS indicates a slightly more expensive valuation: HIMS is more expensive than 60.40% of the companies listed in the same industry.
HIMS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 99.37 | ||
| EV/EBITDA | 70.34 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HIMS may justify a higher PE ratio.
HIMS's earnings are expected to grow with 24.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.6
PEG (5Y)1.09
EPS Next 2Y24.45%
EPS Next 3Y24.18%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
52.54
-5.33 (-9.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.61%
Inst Owner Change0%
Ins Owners10.28%
Ins Owner Change-2.65%
Market Cap11.88B
Analysts68
Price Target49.8 (-5.22%)
Short Float %34.35%
Short Ratio2.15
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.23%
Min EPS beat(2)10.29%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)185.99%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)152.2%
EPS beat(12)11
Avg EPS beat(12)111.23%
EPS beat(16)12
Avg EPS beat(16)74.99%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)6.75%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.23%
Revenue beat(12)9
Avg Revenue beat(12)2.03%
Revenue beat(16)13
Avg Revenue beat(16)3.23%
PT rev (1m)-3.07%
PT rev (3m)-0.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.98%
EPS NY rev (1m)2.89%
EPS NY rev (3m)-9.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.04%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.68 | ||
| Fwd PE | 62.82 | ||
| P/S | 5.9 | ||
| P/FCF | 99.37 | ||
| P/OCF | 45.39 | ||
| P/B | 21.1 | ||
| P/tB | 29.37 | ||
| EV/EBITDA | 70.34 |
EPS(TTM)0.8
EY1.52%
EPS(NY)0.84
Fwd EY1.59%
FCF(TTM)0.53
FCFY1.01%
OCF(TTM)1.16
OCFY2.2%
SpS8.91
BVpS2.49
TBVpS1.79
PEG (NY)4.6
PEG (5Y)1.09
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 23.47% | ||
| ROICexgc | 35.76% | ||
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% | ||
| FCFM | 5.94% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Debt/EBITDA | 5.84 | ||
| Cap/Depr | 486.96% | ||
| Cap/Sales | 7.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 157.56% | ||
| Profit Quality | 61.73% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 | ||
| Altman-Z | 7.31 |
F-Score6
WACC8.77%
ROIC/WACC0.77
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
EPS Next Y14.28%
EPS Next 2Y24.45%
EPS Next 3Y24.18%
EPS Next 5Y41.75%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
Revenue Next Year59.67%
Revenue Next 2Y38.12%
Revenue Next 3Y31.04%
Revenue Next 5Y21.25%
EBIT growth 1Y821.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year358.46%
EBIT Next 3Y94.49%
EBIT Next 5Y60%
FCF growth 1Y927.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y922.97%
OCF growth 3YN/A
OCF growth 5YN/A